Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study
Sebastian, Martin, Passlick, Bernward, Friccius-Quecke, Hilke, Jäger, Michael, Lindhofer, Horst, Kanniess, Frank, Wiewrodt, Rainer, Thiel, Eckhard, Buhl, Roland, Schmittel, Alexander
Published in Cancer Immunology, Immunotherapy (01.10.2007)
Published in Cancer Immunology, Immunotherapy (01.10.2007)
Get full text
Journal Article
Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study
Berek, Jonathan S, Edwards, Robert P, Parker, Lynn P, DeMars, Leslie R, Herzog, Thomas J, Lentz, Samuel S, Morris, Robert T, Akerley, Wallace L, Holloway, Robert W, Method, Michael W, Plaxe, Steven C, Walker, Joan L, Friccius-Quecke, Hilke, Krasner, Carolyn N
Published in International journal of gynecological cancer (01.11.2014)
Published in International journal of gynecological cancer (01.11.2014)
Get full text
Journal Article
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar
Strand, Vibeke, Girolomoni, Giampiero, Schiestl, Martin, Ernst Mayer, Robert, Friccius-Quecke, Hilke, McCamish, Mark
Published in Current medical research and opinion (03.06.2017)
Published in Current medical research and opinion (03.06.2017)
Get more information
Journal Article
Prognostic factors for the efficacy of catumaxomab in patients (pts) with malignant ascites (MA): Meta-analysis from two phase III studies
Friccius-Quecke, Hilke, Heiss, Markus M., Lordick, Florian, Parsons, Simon L., Wimberger, Pauline, Bokemeyer, Carsten
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Results of a phase II clinical trial to evaluate a re-challenge of intraperitoneal catumaxomab for treatment of malignant ascites (MA) due to epithelial cancer (SECIMAS)
Pietzner, Klaus, Vergote, Ignace, Santoro, Armando, Marme, Frederik, Rosenberg, Per, Friccius-Quecke, Hilke, Sehouli, Jalid
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
Pietzner, Klaus, Vergote, Ignace, Santoro, Armando, Chekerov, Radoslav, Marmé, Frederik, Rosenberg, Per, Martinius, Holger, Friccius-Quecke, Hilke, Sehouli, Jalid
Published in Medical oncology (Northwood, London, England) (01.12.2014)
Published in Medical oncology (Northwood, London, England) (01.12.2014)
Get full text
Journal Article
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
Sehouli, Jalid, Pietzner, Klaus, Wimberger, Pauline, Vergote, Ignace, Rosenberg, Per, Schneeweiss, Andreas, Bokemeyer, Carsten, Salat, Christoph, Scambia, Giovanni, Berton-Rigaud, Dominique, Santoro, Armando, Cervantes, Andrés, Trédan, Olivier, Tournigand, Christophe, Colombo, Nicoletta, Dudnichenko, Alexander S., Westermann, Anneke, Friccius-Quecke, Hilke, Lordick, Florian
Published in Medical oncology (Northwood, London, England) (01.08.2014)
Published in Medical oncology (Northwood, London, England) (01.08.2014)
Get full text
Journal Article
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study
Sebastian, Martin, Kiewe, Philipp, Schuette, Wolfgang, Brust, Daniel, Peschel, Christian, Schneller, Folker, Rühle, Karl-Heinz, Nilius, Georg, Ewert, Ralf, Lodziewski, Sven, Passlick, Bernward, Sienel, Wulf, Wiewrodt, Rainer, Jäger, Michael, Lindhofer, Horst, Friccius-Quecke, Hilke, Schmittel, Alexander
Published in Journal of immunotherapy (1997) (01.02.2009)
Published in Journal of immunotherapy (1997) (01.02.2009)
Get more information
Journal Article
Interleukin 10 is a human T cell growth factor in vitro
Pawelec, Graham, Pohla, Heike, Schlotz, Elke, Rehbein, Arnika, Schaudt, Kurt, Hambrecht, Andreas, Friccius, Hilke
Published in Cytokine (Philadelphia, Pa.) (01.05.1995)
Published in Cytokine (Philadelphia, Pa.) (01.05.1995)
Get full text
Journal Article
The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells
Pawelec, G, Adibzadeh, M, Bornhak, S, Friccius, H, Halder, T, Kalbacher, H, Li, K, Max, H, Müller, C, Sansom, D, Thiel, F, Zeuthen, J
Published in Immunological reviews (01.12.1996)
Published in Immunological reviews (01.12.1996)
Get more information
Journal Article
Human γδ Cells Are Resistant to Induction of Anergy but Not to Induction of Cell Death in Vitro
Pawelec, Graham, Friccius, Hilke, Boshell, Martina, Siegels-Hübenthal, Petra, Rehbein, Arnika, Schlotz, Elke, Pohla, Heike, Schaudt, Kurt, Sansom, David
Published in Cellular immunology (15.04.1995)
Published in Cellular immunology (15.04.1995)
Get full text
Journal Article
Requirements for Stimulation or Anergy Induction in Alloreactive Human T Cell Clones
Pawelec, Graham, Kalbacher, Hubert, Pohla, Heike, Boshell, Martina, Max, Heiner, Friccius, Hilke, Adibzadeh, Medi, Hambrecht, Andreas, Sansom, David
Published in Cellular immunology (01.10.1994)
Published in Cellular immunology (01.10.1994)
Get full text
Journal Article